（2）预测接受NAs或PegIFN治疗停药后的复发风险：近年HBV ...

Cancer immunotherapy represents a transformative approach in oncology, especially for treating cancers thought to be incurable. However, a significant ...

肉芽肿性乳腺炎（GM）发病机制不明，严重影响女性健康。研究人员运用单细胞 RNA 测序（scRNA-seq）对比 GM 与正常乳腺组织，发现 GM 组织免疫细胞浸润、多种细胞变化及信号通路异常。这为理解 GM 发病机制和寻找治疗靶点提供依据。

Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.90 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to loss of $0.79 per share a year ago. These ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

A survey released today from the Alliance for mRNA Medicines warns that cuts to biomedical research and threats of anti-mRNA policies risk delays to therapeutic advances in cancer, rare diseases, and ...

基础医学院孙书国/李岩团队 在转录共激活因子YAP/TAZ的转录激活机制和靶向抑制剂开发研究领域取得重要进展！2025年4月24日，在 Nature Communications 上发表题为 The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy 的文章。

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy ...